Suchergebnisse - "Sakr, Wael A."

PubPharm (72)

1

The vulnerable primed cancer stem cells in disguise: demystifying the role of Maspin

enthalten in: Cancer and metastasis reviews | 2022

von Sheng, S. | Bernardo, M. | Dzinic, S. | +2

2

Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review

enthalten in: Cancer and metastasis reviews | 2018

von Sheng, S. | Margarida Bernardo, M. | Dzinic, S. | +3

3

An Essential Role of Maspin in Embryogenesis and Tumor Suppression

enthalten in: Cancer research | 2017

von Dzinic, S. | Bernardo, M. | Li, X. | +22

4

Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients

enthalten in: American journal of translational research | 2016

von Hwang, C. | Sethi, S. | Heilbrun, L. | +8

5

Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes

enthalten in: The prostate | 2015

von Kong, D. | Sethi, S. | Li, Y. | +4

6

SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guérin

enthalten in: The journal of urology | 2013

von Skinner, E. | Goldman, B. | Sakr, W. | +8

7

High-Grade Prostatic Intraepithelial Neoplasia: Additional Links to a Potentially More Aggressive Prostate Cancer?

enthalten in: Journal of the National Cancer Institute | 2013

von Sakr, W.

8

Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer

enthalten in: American journal of translational research | 2013

von Sethi, S. | Kong, D. | Land, S. | +3

9

1666 SWOG S0353 PHASE II TRIAL OF INTRAVESICAL GEMCITABINE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER WHO RECURRED FOLLOWING AT LEAST TWO PRIOR COURSES OF BCG

enthalten in: The journal of urology | 2012

von Skinner, E. | Goldman, B. | Sakr, W. | +7

10

3,3′‐diindolylmethane enhances taxotere‐induced growth inhibition of breast cancer cells through downregulation of FoxM1

enthalten in: International journal of cancer | 2011

von Ahmad, A. | Ali, S. | Wang, Z. | +5

1
2
3
4
5
6
7
8
Nächster »
[8]